These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 22145224)
41. [Current situation in human infections with highly pathogenic avian influenza viruses]. Obuchi M; Tashiro M Nihon Rinsho; 2010 Sep; 68(9):1729-35. PubMed ID: 20845756 [TBL] [Abstract][Full Text] [Related]
42. Synthesis and antiviral activity evaluation of some aminoadamantane derivatives. Kolocouris N; Foscolos GB; Kolocouris A; Marakos P; Pouli N; Fytas G; Ikeda S; De Clercq E J Med Chem; 1994 Sep; 37(18):2896-902. PubMed ID: 8071937 [TBL] [Abstract][Full Text] [Related]
43. Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening. Zhang J; Liu T; Tong X; Li G; Yan J; Ye X Antiviral Res; 2012 Jan; 93(1):48-54. PubMed ID: 22057306 [TBL] [Abstract][Full Text] [Related]
45. [Electronoptical studies of the effect of 1-[p-(methylnitrosamino)-benzylidenamino]-adamantane on the fowl plague virus (FPV) in cell culture]. Zöpel P; Tonew E; Ulbricht H Z Allg Mikrobiol; 1978; 18(7):501-10. PubMed ID: 569933 [TBL] [Abstract][Full Text] [Related]
46. [Preparation and antiviral properties of Bacillus intermedius ribonuclease modified by chloranhydride of adamantanecarboxylic acid]. Kurinenko BM; Kalacheva NV; Muratov PIu Antibiot Khimioter; 1995 Sep; 40(9):17-9. PubMed ID: 8651823 [TBL] [Abstract][Full Text] [Related]
47. The current progress in the use of boron as a platform for novel antiviral drug design. Wang S; Ren Y; Wang Z; Jiang X; Xu S; Zhang X; Zhao S; Zalloum WA; Liu X; Zhan P Expert Opin Drug Discov; 2022 Dec; 17(12):1329-1340. PubMed ID: 36448326 [TBL] [Abstract][Full Text] [Related]
48. Effect of host-cell on antiviral action of acetone. Libshits BA; Yakobson E; Byckovsky AF; Ghendon YZ; Chernos VI Arch Gesamte Virusforsch; 1973; 40(1):164-7. PubMed ID: 4734995 [No Abstract] [Full Text] [Related]
50. Boron-Containing heterocycles as promising pharmacological agents. Das BC; Adil Shareef M; Das S; Nandwana NK; Das Y; Saito M; Weiss LM Bioorg Med Chem; 2022 Jun; 63():116748. PubMed ID: 35453036 [TBL] [Abstract][Full Text] [Related]
51. [The natural content of boron in food products in the Tatar and Mariisk ASSSR]. KHAMIDULLIN RS Vopr Pitan; 1960; 19():81-5. PubMed ID: 14408779 [No Abstract] [Full Text] [Related]
52. Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent? Cetiner E; Sayin K; Tuzun B; Ataseven H Bratisl Lek Listy; 2021; 122(4):263-269. PubMed ID: 33729819 [TBL] [Abstract][Full Text] [Related]
53. Can Carbon Quantum Dots (CQDs) or Boron Compounds be an Ultimate Solution for COVID-19 Therapy? Camlik G; Akkol EK; Degim Z; Degim IT Iran J Pharm Res; 2021; 20(4):9-20. PubMed ID: 35194423 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Gubareva LV; Penn CR; Webster RG Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401 [TBL] [Abstract][Full Text] [Related]
55. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Ehrhardt C; Hrincius ER; Korte V; Mazur I; Droebner K; Poetter A; Dreschers S; Schmolke M; Planz O; Ludwig S Antiviral Res; 2007 Oct; 76(1):38-47. PubMed ID: 17572513 [TBL] [Abstract][Full Text] [Related]
56. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Ikematsu H; Kawai N Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296 [TBL] [Abstract][Full Text] [Related]
58. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. Nacken W; Ehrhardt C; Ludwig S Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315 [TBL] [Abstract][Full Text] [Related]